Back to search
Non-severe Pulmonary Embolism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-severe Pulmonary Embolism trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-severe Pulmonary Embolism trials you may qualify forThis study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on the prevention of Cancer-Associated Thrombosis (CA…
The objective of the study is to evaluate the prognostic performance of the chair lift test in the initial assessment of the severity of non-severe pulmonary em…
In France, venous thromboembolism (VTE), which includes pulmonary embolism (PE) and deep-vein thrombosis (DVT), is the 3rd leading cause of cardiovascular disea…
Patients with moderate to severe COVID-19 present a very high risk of thromboembolic disease.This multicenter, prospective, randomized, event-driven study evalu…
Severe SARS-CoV-2 infection, responsible of COVID-19, is accompanied by many venous thromboembolic events. Antithrombotic treatment is the cornerstone of manage…